Critical Therapeutics Sales Aid For Asthma Drug Zyflo Prompts FDA Warning Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
The company must include risk information on a one-page sheet used by sales reps to illustrate zileuton’s mechanism of action to physicians, the agency’s ad division says.